Ichtiolowa Hasco

Ichthammol, the active ingredient in Ichtiolowa Hasco, is a topical anti‑inflammatory/antiseptic presented as a topical preparation for topical use. It treats skin inflammation, abscesses, furunculosis, dermatitis and acne in adults and children.

GNH USA supplies Ichtiolowa Hasco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ichtiolowa Hasco is a topical anti‑inflammatory/antiseptic used for various skin conditions. - Skin inflammation: reduces redness, swelling and discomfort. - Abscesses: promotes drainage and limits bacterial growth. - Furunculosis: helps resolve boils and prevents spread. - Dermatitis: alleviates irritation and itching. - Acne: decreases inflammatory lesions and supports healing.

Topical application of Ichtiolowa Hasco may cause local reactions.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Itching: transient pruritus after use. - Burning sensation: brief warmth or stinging. - Dryness: mild desiccation of the treated area.

Serious or Rare Side Effects: - Severe allergic reaction: signs of anaphylaxis such as swelling, difficulty breathing. - Bullous dermatitis: formation of large blisters. - Ulceration: deep skin breakdown beyond expected irritation. - Pigment changes: unexpected discoloration of the skin. - Systemic toxicity: extremely rare systemic effects from excessive absorption.

Use Ichtiolowa Hasco with attention to safety considerations. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: insufficient data; weigh potential risks. - Age: not recommended for infants under 2 years without medical advice. - Allergy: avoid if known hypersensitivity to ichthammol or related compounds. - Application: apply a thin layer to clean skin; avoid eyes, mucous membranes. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ichtiolowa Hasco may interact with other topical agents.

Major Interactions (Avoid): - Concurrent potent topical steroids: may mask infection signs. - Use with occlusive dressings: increases systemic absorption risk. - Combination with other keratolytic agents: may cause excessive irritation.

Moderate Interactions (Monitor Closely): - Co‑application with topical antibiotics: monitor for additive irritation. - Use with antihistamine creams: may reduce anti‑inflammatory efficacy.